John S. Hollinsworth Sells 92,500 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Stock

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) EVP John S. Hollinsworth sold 92,500 shares of the company’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $74.01, for a total transaction of $6,845,925.00. Following the completion of the transaction, the executive vice president now owns 84,630 shares of the company’s stock, valued at approximately $6,263,466.30. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Acadia Healthcare Trading Down 1.7 %

Shares of NASDAQ:ACHC opened at $72.71 on Friday. The company has a 50 day moving average of $72.41 and a 200-day moving average of $73.46. The firm has a market cap of $6.71 billion, a P/E ratio of -346.24, a P/E/G ratio of 1.97 and a beta of 1.44. Acadia Healthcare Company, Inc. has a twelve month low of $66.49 and a twelve month high of $89.85. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.50.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Royal Bank of Canada decreased their target price on shares of Acadia Healthcare from $99.00 to $94.00 and set an “outperform” rating for the company in a research report on Tuesday, November 7th. TheStreet cut shares of Acadia Healthcare from a “b” rating to a “c” rating in a research report on Friday, November 3rd. Cantor Fitzgerald upped their price target on shares of Acadia Healthcare from $83.00 to $85.00 and gave the stock a “neutral” rating in a research note on Thursday, September 14th. Finally, StockNews.com assumed coverage on shares of Acadia Healthcare in a research note on Thursday, October 5th. They issued a “hold” rating for the company. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $85.71.

Institutional Trading of Acadia Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Acadia Healthcare by 1.5% during the third quarter. Vanguard Group Inc. now owns 8,758,004 shares of the company’s stock valued at $684,700,000 after purchasing an additional 131,959 shares during the last quarter. Wellington Management Group LLP lifted its stake in Acadia Healthcare by 17.8% during the first quarter. Wellington Management Group LLP now owns 5,626,846 shares of the company’s stock valued at $406,540,000 after purchasing an additional 850,056 shares during the last quarter. FMR LLC lifted its position in shares of Acadia Healthcare by 117.7% in the 1st quarter. FMR LLC now owns 5,279,609 shares of the company’s stock valued at $381,452,000 after acquiring an additional 2,854,393 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Acadia Healthcare by 0.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 3,361,534 shares of the company’s stock valued at $267,713,000 after acquiring an additional 15,177 shares in the last quarter. Finally, William Blair Investment Management LLC lifted its position in shares of Acadia Healthcare by 0.3% in the 3rd quarter. William Blair Investment Management LLC now owns 3,058,916 shares of the company’s stock valued at $215,072,000 after acquiring an additional 10,062 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. It offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, eating disorder facilities, and outpatient clinics.